Rare case of rilpivirine-induced severe allergic hepatitis

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 2, 2013, Pages 484-486

  Ahmed, Yasir ^a   Siddiqui, Wajid ^a   Enoch, Caroline B ^b   Albrecht, Helmut ^a   Brandon Bookstaver, P ^b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antiretrovirals; Drug induced hypersensitivity reactions; Non nucleoside reverse transcriptase inhibitors

Indexed keywords

AMLODIPINE; ATAZANAVIR; ATOVAQUONE; AZITHROMYCIN; CARVEDILOL; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ETHAMBUTOL; RALTEGRAVIR; RILPIVIRINE; RITONAVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CASE REPORT; CD4 LYMPHOCYTE COUNT; DISTRESS SYNDROME; FEVER; HEART RATE; HEPATITIS; HUMAN; LETTER; MALE; NAUSEA; PARATUBERCULOSIS; VIRUS LOAD; VOMITING; WEAKNESS;

ADULT; ANTI-RETROVIRAL AGENTS; DRUG HYPERSENSITIVITY; HEPATITIS; HUMANS; LIVER FUNCTION TESTS; MALE; NITRILES; PYRIMIDINES; TIME FACTORS;

EID: 84872419202     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks400     Document Type: Letter

References (11)

1. Castell JV, Castell M. Allergic hepatitis induced by drugs. Curr Opin Allergy Clin Immunol 2006; 6: 258-65.
2. Dieterich DT, Robinson PA, Love J et al. Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors. Clin Infect Dis 2004; 38 SUPPL 2: S80-9.
3. Abrescia N, D'Abbraccio MD, Figoni M et al. Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatmentnaive female AIDS patient without hepatitis virus co-infection. J Antimicrob Chemother 2002; 50: 763-5.
4. Podevin P, Biour M. Drug-induced 'allergic hepatitis'. Clin Rev Allergy Immunol 1995; 13: 223-44.
5. Boelsterli UA, Zimmerman HJ, Kretz-Rommel A. Idiosyncratic liver toxicity of nonsteroidal antiinflammatroy drugs: molecular mechanisms and pathology. Crit Rev Toxicol 1995; 25: 207-35.
6. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
7. Selzentry (maraviroc) (Package Insert). Research Triangle Park, NC: ViiV Healthcare, 2012.
8. Shapiro M, Ward KM, Stern JJ. A near-fatal hypersensitivity reaction to abacavir: case report and literature review. AIDS Read 2001; 11: 222-6.
9. Johnson S, Chan J, Bennett CL. Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen. Ann Intern Med 2002; 137: 146-7.
10. Edurant (rilpivirine) (Package Insert). Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc., 2011.
11. Nelson M, Amaya G, Clumeck N et al. Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/ hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials. J Antimicrob Chemother 2012; 67: 2020-8.